Monkeypox healthliteracy and vaccine information

The WHO Public Health Emergency of International Concern (PHEIC) about the Monkeypox for the second time since 2022 is based on 4 deaths and 934 laboratory cases reported to the WHO in June 2024 from 26 countries. Reported by lawyer Tom Renz from the USA.

“global health emergency.” This is only true if the definition of global health emergency is “finding a means to transfer money from the US coffers to Bill Gates, Pfizer, and the globalist WHO cabal.” Tom Renz

This image below shows the WHO data for the Monkeypox PHEIC declaration:

On X I get a different set of IFR (infection fatality rate) depending on what sources they use (that both relate to WHO reporting) for reporting on the second Monkeypox PHEIC. The image above states 208 deaths of 99 176 cases since January 2022 that is WHO official information. Dr. Tim Goyetche ND, Former WHO consultant on epigenetics on the other hand used the Our World in Data as a source and seems to have other kinds of information about the monkeypox deaths: “MONKEYPOX UNCENSORED FACTS: Globally, the survival rate after getting a monkeypox infection is 99.942%. Of the 80,850 cases of monkeypox that have been documented since 2022, only 55 of them died. And no comorbidities, locations, or possible socioeconomic factors are identified.” Is the WHO offical information false in comparison to a physician now apparently critical of the WHO?

Our World in Data:

• “Vaccination against smallpox offers some degree of protection against mpox. Smallpox was eradicated in 1980, so vaccination rates against it have dropped since then. This means the protection it provided against mpox has diminished¹, leading to a gradual increase in cases in West and Central Africa.

• In May 2022, a notable outbreak of mpox spread across the world. This global outbreak was primarily, but not exclusively, driven through transmission via sexual contact of men who have sex with men². The combination of public health campaigns, availability of vaccines, and actions by impacted communities led to fewer infections globally.

• Although global cases have markedly declined, mpox persists in many countries in West and Central Africa. A lack of local diagnostic infrastructure means suspected mpox cases are often not confirmed and, therefore, are not included in data collected by the WHO.

• We maintain a data explorer on this page, which lets you explore confirmed cases and death counts regularly published by the World Health Organization.”
  

The image above is the current latest image from Our World in Data still published even on August 16, 2024.

Dr. Meryl Nass comments the WHO monkeypox PHEIC nr 2 and the IFR claims from the WHO:

• The claim is that 3.7% of cases result in death—which is higher than what was claimed for COVID at the start: 14,000 cases and 524 deaths (most in children) in 2024. This is extremely unlikely for a number of reasons.

• Addendum: In the 2 hrs since the WHO announced the numbers above at its press conference today, the WHO’s numbers (in a press release) have risen: over 15,600 cases and 537 deaths.

• a) This is 20 times higher than the death rate for the 2022-23 monkeypox outbreak

• b) Obtaining an accurate death rate in the Democratic Republic of Congo where there are few roads and very little modern infrastructure is impossible. In fact Dr. Ogoina, chair of the WHO expert committee, said in today’s press conference that there is underreporting of cases. He also noted that some deaths were in patients with advanced HIV disease.

• c). We were initially told that monkeypox had a 1-10% mortality rate in Africa, which may or may not be true, but the mortality rate in the west was more like 0.1%

• Dr. Ogoina also said this is a “new form of monkeypox” with “atypical lesions”—so what we need is to look at the genome and get an idea where it came from.

---

The questions and points Dr. Meryl Nass are making make very good sense if one compares to Covid where the WHO on X at the time of the Covid-19 PHEIC claimed the IFR of Sars-Cov-2 was 3.4 % (the spanish flu had 2.2 % IFR). In Sweden for Covid-19 the swedish government “miscalculated” the IFR rate of Sars-CoV-2 by 1000 % to be able to pass a temporary Pandemic Act in Sweden.

SkyNews put out an alarming report due to the PHEIC nr. 2 about there being 17 500 cases since January 2024 and 15 000 cases in 2023. 15 000 Cases in the Congo and 500 deaths since January 2024. Why are these numbers not shown in the Our World in Data that reports on the WHO reporting and these numbers do not even correspond to the first mapping that also comes from WHO reporting that showed 208 deaths of 99 176 cases since 2022 - these numbers are not shown in the Our World in Data.

Thailand Medical News reported on deliberate silencing: “Why the #@%&! is not the WHO pushing for containment strategies to control Mpox spread by imposing travels bans etc instead of advocating for freedom to travel that will simply spread the pathogen by people leaving Africa. It seems they want it to spread! Also they only declared it an emergency just after letting it spread to many countries in the Middle-East such as UAE, Saudi Arabia, Bahrain etc over the last 4 weeks and everything was hushed up then! Cases in Middle east is actually bad now! Major concealment!”

Thailand Medical News on more silencing: This is getting serious! I too was very skeptical about the WHO's Mpox announcement & felt that it was only clade I and that it would be mostly restricted to Africa but in the last few hours as I persue through lots of reports & data all I can say that it is really going to be super bad and these motherfuckers (sorry for my language) are planning the whole game & also withheld a lot of data for the last 3 months! There are 4 strains of Mpox and not three if we include clade Ib plus clade I and clade II..there is also clade 1bplus! Check out patents & also also things are are under production & see the companies involved etc...everything started around October 2023! There are lots of infections of clade 1b in the Middle East that is being concealed! Clade Ib plus is even interesting!

Is it to an attempt from the WHO to push for their WHO Pandemic Treaty?

Added in August 17 from the World Council for Health (excerpt). I knew there was something strange with the numbers.

• The Democratic Republic of Congo (DRC) is currently experiencing a severe outbreak, with 14,000 cases and 5 deaths at time of writing. Since 2023, the DRC has reported about 12,600 suspected cases and 580 deaths, a sharp rise from previous years, according to the CDC. The disease is also spreading to neighboring countries, with 50 confirmed cases reported in Burundi, Kenya, Rwanda and Uganda.

• In 2022 overall, 98% of infected people were gay or bisexual men, 75% were white, and 41% had human immunodeficiency virus infection; the median age was 38 years. Transmission was suspected to have occurred through sexual activity in 95% of the people infected. While the strain responsible for the current outbreak, clade 1b, is more severe, only a fraction of cases (10%) have been lab-confirmed so far.

• It is important to note that traditional public health measures such as contract tracing and quarantining have consistently controlled spread of the disease. So, why is the WHO’s health response purely focused on vaccines?

• While declaring a PHEIC, the WHO has also invited ‘Mpox vaccine manufacturers’ to submit their latest shot for emergency approval. The Emergency Use Listing process is used to speed up the authorization of unlicensed vaccines, therapeutics, and tests. The highly inappropriate PCR test is again being recommended.

The Childrens Health Defense reported: "For nearly nine years Dr. Anthony Fauci’s institute concealed plans to engineer a pandemic capable mpox, formerly known as monkeypox, virus with a case fatality rate of up to 15%, congressional investigators revealed in a new report..."

Sweden it seems has its first Monkeypoxvirus case one day after the WHO declared the second PHEIC about monkeypox. The first case outside of Africa. In 2020 Sweden only needed one Sars-Cov-2 contagion to declare Covid-19 as a pandemic. During the Swineflu it took 10 cases in Sweden for a pandemic declaration.

Added in later the same day: John Campbell explained the first case of the more severe strain of the mpox is due to a person travelling to Sweden from Congo. John Campbell ses the mpox as a serious problem mostly in the Congo - not really the rest of the world. Clade 1 mpox is the more severe form that causes illness and death (endemic to Central Africa). Clade 2 caused the outbreak in 2022 and has a 99.9 % survival rate (endemic to West Africa). Transmission - close contact or face to face (droplets or short ranged aerosols).

The mpox is now also airborne (GoF) and most probably a Gain-of-Function virus. Usually mpox spreads by close contact or sexual contacts and has been more usual amoung homosexual men before. Previously reported on Patientmakt about Congo: Congo an airborne monkeypox variant clade B1 is spreading in schools, workplaces and from mother to child in Congo. The clade B1 has a 5 % fatality rate for adults and a 10 % fatality rate for children. Get more information from this previous post and there are also alternative treatment options and where Dr. Meryl Nass questions the efficacy of the monkeypox vaccines (antibody response but do not protect against disease):

Information on monkeypox vaccines - they are not always administered as vaccines usually are with a needle but use a bifurcated needle that requires 15 pokes. The area must be covered until the scab falls off (after 2 - 4 weeks) otherwise there is risk of spreading the monkeypox virus to other parts of the body or to other people.

There are known side-effects of the monkeypox vaccines that can be used. As I read the scientific article, Monkeypox (Mpox) vaccines and their side effects: the other side of the coin, this is the information Dr Tim Goyetche used for calculating survival rate about monkeypox from the first PHEIC declared in 2022 by the WHO and I am wondering if it also accounts for the now airborne one or not: “As of 23 November 2022, the total number of confirmed Mpox cases is 80,850, with 55 deaths involving 110 countries, out of which 103 are nonendemic”.

There are currently three vaccines that can be used against the monkeypox virus: ACAM2000 (second-generation and MVA-BN, not approved for Mpox but requires informed consent), MVA-BN (third-generation smallpox vaccine, the only one approved against Mpox), LC-16 (third-generation smallpox vaccine).

ACAM200 side effects: injection site pain, lymph node pain, pruritus, and other flu-like symptoms, itching, myalgia, headache, sore arm, rash, fever, and fatigue, ocular vaccinia can occur in some of the exposed persons leading to symptoms like – painful watery eyes with blurred vision, scarring of cornea, keratitis, and blindness, severe and long-term side effects like myopericarditis have been reported to be found in approximately every 20 individuals out of 100,000 ACAM2000 vaccine recipients, neurological events, myocarditis/pericarditis have been found to be 1 in 175, infected blister over the vaccination site, severe allergic reaction (eczema vaccinatum), disseminated infection to the other parts of the body (progressive vaccinia), encephalitis, encephalomyelitis, and encephalopathy, and even death, Risk factors for serious side effects can be – underlying skin diseases/allergic conditions, cardiac diseases, immunocompromised status, smoking, high blood pressure, high blood sugar/cholesterol, pregnancy, lactation, use of steroid eye drops, etc. There is a risk of stillbirth or fetal death due to ACAM2000 vaccination in pregnant women. ACAM2000 live vaccinia virus from lactating mothers to infants is a critical concern. Individuals allergic to neomycin and polymyxin B are at an increased risk due to the presence of these antibiotics in ACAM2000.

MVA-BN side effects: injection site, reactions like redness, firmness/tightening, pain, induration, itching, sore throat, myalgia, headache, chills, and nausea, cardiac events.

LC-16m8 side effects: Mild to moderate local and systemic adverse events are very common with this vaccine. Myopericarditis. The vaccine is not recommended for widespread vaccination among immunocompromised and atopic dermatitis patients. More information on the LC-16 vaccine: LC16m8: An attenuated smallpox vaccine

The Childrens Health Defense reported (added in):

WHO-recommended live virus vaccines, Jynneos & ACAM2000, are:

(a) intended for smallpox and experimental for monkeypox

(b) reported serious adverse effects

(c) contain live viral strains which may instigate a resurgence of the eradicated smallpox virus

Article in full: ‘No Justification’: South African Vaccine Injury Group Warns Against Mpox Vaccine

Thailand Medical News reported:

Vaccinia Virus Tiantan is not working against mpox (chinese study)

Article in full: Chinese researchers warn that current vaccines are inefficient in protecting against emerging Mpox virus

In 2022 Dr. Mercola reported: “Moderna already has a monkeypox vaccine in pre-clinical trials.” And as reported by Reuters in 2022: “Moderna did not immediately respond to a request for more details on the monkeypox vaccines.”

Added in about 2024: the UK is testing an mRNA injection against mpox: “Researchers from University Hospitals Bristol and Weston NHS Foundation Trust are hoping to recruit another 175 volunteers to the study”. Should one make the same conclusions as about previous mRNA injections? They use the most dangerous part of the virus and there is only a more or less 1 % actual protection rate?

From a different article on the Dr. Mercola website in 2022:

• The idea that smallpox vaccines may be effective against monkeypox comes from a 1988 non-randomized observational study¹³ in which 0.96% of vaccinated close contacts contracted monkeypox, compared to 7.47% of unvaccinated close contacts.

• Two of the biggest problems with this assumption are that a) the vaccine used in that 1988 study was a first-generation vaccine that is no longer in use, and b) the current strain of monkeypox has undergone many mutations since 1988. So, there’s really no telling whether the vaccine will have any benefit at all.

• As noted by Ira Longini, Ph.D., a biostatistician at the University of Florida and a WHO adviser, “The truth is, we don’t know the efficacy of any of these monkeypox vaccines.”